Nicotine and vascular endothelial dysfunction in female ovariectomized rats: Role of estrogen replacement therapy

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 1, 2012, Pages 108-119

  El Seweidy, Mohamed M ^a   Mohamed, Hoda E ^a   Asker, Mervat E ^a   Atteia, Hebatallah H ^a  

^a Zagazig University   (Egypt)

Author keywords

atherogenic index; eNOS; ERT; nicotine; ovariectomy; VED

Indexed keywords

CALCIUM; CASPASE 3; CYCLIC GMP; ENDOTHELIN 1; ESTRADIOL; ESTRADIOL BENZOATE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYPROLINE; LIPID; MALONALDEHYDE; MESSENGER RNA; NICOTINE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; GENE EXPRESSION; GLUTATHIONE METABOLISM; LIPID BLOOD LEVEL; MENOPAUSE; NONHUMAN; OXIDATIVE STRESS; PASSIVE SMOKING; PROTECTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SHORT COURSE THERAPY; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASODILATATION; WEIGHT REDUCTION;

ANIMALS; AORTA, THORACIC; ATHEROSCLEROSIS; CALCIUM; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYDROXYPROLINE; LIPIDS; MALONDIALDEHYDE; MODELS, ANIMAL; NICOTINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OVARIECTOMY; OXIDATIVE STRESS; RATS; RATS, WISTAR;

EID: 83555165923     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01377.x     Document Type: Article

References (65)

1. Balakumar P, et al,. Ameliorative effect of combination of benfotiamine and fenofibrate in diabetes-induced vascular endothelial dysfunction and nephropathy in the rat. Mol Cell Biochem 2009; 320: 149-162; doi:10.1007/s11010-008-9917-z.
2. Balakumar P, et al,. Potential target sites to modulate vascular endothelial dysfunction: current perspectives and future directions. Toxicology 2008; 245: 49-64.
3. Ciurea E, et al,. Nutritional antioxidant effects on endothelial dysfunctions in experimental atherosclerosis by ovariectomy. Rev Med Chir Soc Med Nat Iasi 2009; 113: 826-831.
4. Nicita-Mauro V, et al,. Smoking, aging and the centenarians. Exp Gerontol 2008; 43: 95-101.
5. Jiang DJ, et al,. Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction. Biochem Biophys Res Commun 2006; 349: 683-693.
6. Fleming LE, et al,. Earlier age at menopause, work, and tobacco smoke exposure. Menopause 2008; 15: 1103-1108.
7. Okoli CT, et al,. Secondhand smoke and nicotine exposure: a brief review. Addict Behav 2007; 32: 1977-1988. (Pubitemid 47202052)
8. Pasupathi P, et al,. Cigarette smoking-effect of metabolic health risk: a review. Diabetes Metab Syndr Clin Res Rev 2009; 3: 120-127.
9. Ahijevych K, Wewers ME,. Passive smoking and vascular disease. J Cardiovasc Nurs 2003; 18: 69-74.
10. Erusalimsky JD,. Vascular endothelial senescence: from mechanisms to pathophysiology. J Appl Physiol 2009; 106: 326-332.
11. Reckelhoff JF, Maric C,. Sex and gender differences in cardiovascular-renal physiology and pathophysiology. Steroids 2010; 75: 745-746.
12. Yang XP, Reckelhoff JF,. Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens 2011; 20: 133-138.
13. Rossouw JE, et al,. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297: 1465-1477. (Pubitemid 46556472)
14. Alexandersen P, et al,. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women. Climacteric 2006; 9: 108-118.
15. Klaiber EL, et al,. Relationships of serum estradiol levels, menopausal duration, and mood during hormonal replacement therapy. Psychoneuroendocrinology 1997; 22: 549-558. (Pubitemid 27505114)
16. Manson JE, et al,. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007; 356: 2591-2602. (Pubitemid 46961004)
17. Rivera CM, et al,. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009; 16: 15-23.
18. Mendelsohn ME,. Estrogen actions in the cardiovascular system. Climacteric 2009; 12 (Suppl. 1): 18-21.
19. Dantas AP, et al,. Relative contribution of estrogen withdrawal and gonadotropins increase secondary to ovariectomy on prostaglandin generation in mesenteric microvessels. J Cardiovasc Pharmacol 2004; 43: 48-55. (Pubitemid 38032063)
20. Gimenez J, et al,. Effects of oestrogen treatment and angiotensin-converting enzyme inhibition on the microvasculature of ovariectomized spontaneously hypertensive rats. Exp Physiol 2006; 91: 261-268.
21. Micu AL, et al,. Rat hepatic CYP2E1 is induced by very low nicotine doses: an investigation of induction, time course, dose response, and mechanism. J Pharmacol Exp Ther 2003; 306: 941-947. (Pubitemid 37025299)
22. Chen Y, et al,. Estrogen-replacement therapy promotes angiogenesis after acute myocardial infarction by enhancing SDF-1 and estrogen receptor expression. Microvasc Res 2009; 77: 71-77.
23. Korde A, et al,. A radioimmunoassay for serum estradiol. J Radioanal Nucl Chem 1996; 206: 219-226. (Pubitemid 26267555)
24. Moshage H, et al,. Nitrite and nitrate determination in plasma. A critical evaluation. Clin Chem 1995; 41: 892-896.
25. Porstmann T, Kiessig ST,. Enzyme immunoassay techniques, an overview. J Immunol Methods 1992; 150: 5-21.
26. Meiattini F, et al,. The 4-hydroxybenzoate/4-aminophenazone chromogenic system used in the enzymatic determination of serum cholesterol. Clin Chem 1978; 24: 2161-2165. (Pubitemid 9079585)
27. Grove TH,. Effect of reagent pH on determination of HDL cholesterol by precipitation with sodium phosphotungestate-magnesium. Clin Chem 1979; 25: 560-564. (Pubitemid 9166991)
28. Fossati P, Prencipe L,. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982; 28: 2077-2080. (Pubitemid 12034053)
29. Friedewald WT, et al,. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
30. Sagud M, et al,. Lipid levels in female patients with affective disorders. Psychiatry Res 2009; 168: 218-221.
31. Ahmed AE, et al,. Studies on mechanism of haloacetonitrile induced gastrointestinal toxicity, interaction of dibromoacetonitrile with glutathione as glutathione-s-transferase in rats. J Biol Toxicol 1991; 612: 115-121.
32. Buege J, Aust S,. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-306.
33. Campillo N, et al,. Selenium determination in biological fluids using Zeeman background correction electrothermal atomic absorption spectrometry. Anal Biochem 2000; 280: 195-200. (Pubitemid 30308072)
34. Fujita M, et al,. Over expression of tumor necrosis factor β diminishes pulmonary fibrosis induced by bleomycin or transforming growth factor β. Am J Respir Cell Mol Biol 2003; 29: 1-7.
35. Kojda G, et al,. Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ Res 1996; 78: 91-101. (Pubitemid 26004125)
36. Wang S, et al,. Fluorescein provides a resonance gate for FRET from conjugated polymers to DNA intercalated dyes. J Am Chem Soc 2004; 126: 5446-5451. (Pubitemid 38596356)
37. Biegon A, et al,. Nicotine blocks brain estrogen synthase (aromatase): in vivo positron emission tomography studies in female baboons. Biol Psychiatry 2010; 67: 774-777.
38. Parente RC, et al,. The relationship between smoking and age at the menopause: a systematic review. Maturitas 2008; 61: 287-298.
39. Tanko LB, Christiansen C,. An update on the antiestrogenic effect of smoking: a literature review with implications for researchers and practitioners. Menopause 2004; 11: 104-109. (Pubitemid 40362206)
40. Raval AP, et al,. Chronic nicotine exposure inhibits 17beta-estradiol- mediated protection of the hippocampal CA1 region against cerebral ischemia in female rats. Neurosci Lett 2009; 458: 65-69.
41. Balakumar P, et al,. Benfotiamine attenuates nicotine and uric acid induced vascular endothelial dysfunction in the rat. Pharmacol Res 2008; 58: 356-363.
42. Novella S, et al,. Gathering of aging and estrogen withdrawal in vascular dysfunction of senescent accelerated mice. Exp Gerontol 2010; 45: 868-874.
43. Fenoy FJ, et al,. Acute effects of 2-methoxyestradiol on endothelial aortic No release in male and ovariectomized female rats. Nitric Oxide 2010; 23: 12-19.
44. Salhotra S, et al,. Influence of menopause on biochemical markers of endothelial dysfunction-a case-control pilot study in North Indian population. Maturitas 2009; 62: 166-170.
45. Fang Q, et al,. Inhibition of NADPH oxidase improves impaired reactivity of pial arterioles during chronic exposure to nicotine. J Appl Physiol 2006; 100: 631-636. (Pubitemid 43671618)
46. Muñoz-Castañeda JR, et al,. Estradiol and catecholestrogens protect against adriamycin-induced oxidative stress in erythrocytes of ovariectomized rats. Toxicol Lett 2006; 160: 196-203. (Pubitemid 41628106)
47. Hayashi T, et al,. Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 1995; 214: 847-855.
48. Strehlow K, et al,. Modulation of antioxidant enzyme expression and function by estrogen. Circulation Res 2005; 93: 170-177.
49. Emre A, et al,. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-α IVS1-397 C/C genotype and established coronary artery disease. Cardiology 2006; 106: 44-50. doi:10.1159/000092598. (Pubitemid 43999332)
50. Chattopadhyay K, Chattopadhyay BD,. Effect of nicotine on lipid profile, peroxidation & antioxidant enzymes in female rats with restricted dietary protein. Indian J Med Res 2008; 127: 571-576.
51. Vassalle C, et al,. Effects of the estrogen replacement therapy on different biochemical markers of endothelial reactivity in recent postmenopausal healthy women. Immuno-Anal Biol Spec 2005; 20: 181-185. (Pubitemid 40807168)
52. Babaei P, et al,. Effects of ovariectomy and estrogen replacement therapy on visceral adipose tissue and serum adiponectin levels in rats. Menopause Int 2010; 16: 100-104.
53. Balakumar P, Kaur J,. Is nicotine a key player or spectator in the induction and progression of cardiovascular disorders? Pharmacol Res 2009; 60: 361-368.
54. Wang LL, et al,. Estradiol pretreatment attenuated nicotine-induced endothelial cell apoptosis via estradiol functional membrane receptor. Int Immunopharmacol 2011; 215: 309-315 [Epub ahead of print].
55. Hamilton KL, et al,. Effect of ovariectomy on cardiac gene expression: inflammation and changes in SOCS gene expression. Physiol Genomics 2008; 32: 254-263. (Pubitemid 351186331)
56. Pechenino AS, et al,. Impact of aging vs. estrogen loss on cardiac gene expression: estrogen replacement and inflammation. Physiol Genomics 2011; 43: 1065-1073 [Epub ahead of print].
57. Matsuda N, et al,. Silencing of caspase-8 and caspase-3 by RNA interference prevents vascular endothelial cell injury in mice with endotoxic shock. Cardiovasc Res 2007; 76: 132-140. (Pubitemid 47362040)
58. Subramanian M, Shaha C,. Oestrogen modulates human macrophage apoptosis via differential signalling through oestrogen receptor-alpha and beta. J Cell Mol Med 2009; 13: 2317-2329.
59. Rodella LF, et al,. Endothelin-1 as a potential marker of melatonin's therapeutic effects in smoking-induced vasculopathy. Life Sci 2010; 87: 558-564.
60. Tan Z, et al,. Mechanisms of 17β-estradiol on the production of ET-1 in ovariectomized rats. Life Sci 2003; 73: 2665-2674. (Pubitemid 37123118)
61. Zemse SM, et al,. Restoration of endothelin-1-induced impairment in endothelium-dependent relaxation by interleukin-10 in murine aortic rings. Can J Physiol Pharmacol 2008; 86: 557-565.
62. Park JH, et al,. Relationship between arterial calcification and bone loss in a new combined model rat by ovariectomy and vitamin D(3) plus nicotine. Calcif Tissue Int 2008; 83: 192-201.
63. Wu SY, et al,. Endothelin-1 is a potent regulator in vivo in vascular calcification and in vitro in calcification of vascular smooth muscle cells. Peptides 2003; 24: 1149-1156. (Pubitemid 37386301)
64. Widyantoro B, et al,. Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to- mesenchymal transition. Circulation 2010; 121: 2407-2418. Epub 2010 May 24.
65. Park JB, Schiffrin EL,. Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1. Am J Hypertens 2002; 15 (2 Pt 1): 164-169. (Pubitemid 34161092)